BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Najafi M, Farhood B, Mortezaee K. Contribution of regulatory T cells to cancer: A review. J Cell Physiol 2019;234:7983-93. [PMID: 30317612 DOI: 10.1002/jcp.27553] [Cited by in Crossref: 67] [Cited by in F6Publishing: 86] [Article Influence: 16.8] [Reference Citation Analysis]
Number Citing Articles
1 Lentz LS, Stutz AJ, Meyer N, Schubert K, Karkossa I, von Bergen M, Zenclussen AC, Schumacher A. Human chorionic gonadotropin promotes murine Treg cells and restricts pregnancy-harmful proinflammatory Th17 responses. Front Immunol 2022;13:989247. [DOI: 10.3389/fimmu.2022.989247] [Reference Citation Analysis]
2 Yang G, Jiang J, Yin R, Li Z, Li L, Gao F, Liu C, Zhan X. Two novel predictive biomarkers for osteosarcoma and glycolysis pathways: A profiling study on HS2ST1 and SDC3. Medicine (Baltimore) 2022;101:e30192. [PMID: 36086752 DOI: 10.1097/MD.0000000000030192] [Reference Citation Analysis]
3 Indini A, Fiorilla I, Ponzone L, Calautti E, Audrito V. NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets. IJMS 2022;23:9985. [DOI: 10.3390/ijms23179985] [Reference Citation Analysis]
4 Garcia-alvarez A, Hernando J, Carmona-alonso A, Capdevila J. What is the status of immunotherapy in thyroid neoplasms? Front Endocrinol 2022;13:929091. [DOI: 10.3389/fendo.2022.929091] [Reference Citation Analysis]
5 Gürbüz M, Aktaç Ş. Understanding the role of vitamin A and its precursors in the immune system. Nutrition Clinique et Métabolisme 2022;36:89-98. [DOI: 10.1016/j.nupar.2021.10.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Amarillo D, Brugnini A, Trías N, Rodriguez Sande V, Salisbury S, Cuello M, Lens D. Circulating T regulatory cell subsets in patients with untreated lung cancer. Clin Transl Oncol 2022. [PMID: 35445283 DOI: 10.1007/s12094-022-02827-6] [Reference Citation Analysis]
7 Abbas G, Maqbool S, Shahzad MK, Afzaal M, Daud MU, Fatima NG, Ghuffar A. Analysis of gold nanospheres, nano ellipsoids, nanorods, and effect of core-shell structures for hyperthermia treatment. RSC Adv 2022;12:9292-8. [PMID: 35424852 DOI: 10.1039/d2ra00618a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bandaru SS, Boyilla R, Merchant N, Nagaraju GP, El-rayes B. Targeting T regulatory cells: their role in colorectal carcinoma progression and current clinical trials. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106197] [Reference Citation Analysis]
9 Yang X, Li X, Cheng Y, Zhou J, Shen B, Zhao L, Wang J. Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer. Front Cell Dev Biol 2022;9:797826. [DOI: 10.3389/fcell.2021.797826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Huntemann N, Bittner S, Bock S, Meuth SG, Ruck T. Mini-Review: Two Brothers in Crime - The Interplay of TRESK and TREK in Human Diseases. Neurosci Lett 2021;769:136376. [PMID: 34852287 DOI: 10.1016/j.neulet.2021.136376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Harrell CR, Volarevic A, Djonov VG, Jovicic N, Volarevic V. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Int J Mol Sci 2021;22:12429. [PMID: 34830312 DOI: 10.3390/ijms222212429] [Reference Citation Analysis]
12 Ruck T, Bock S, Pfeuffer S, Schroeter CB, Cengiz D, Marciniak P, Lindner M, Herrmann A, Liebmann M, Kovac S, Gola L, Rolfes L, Pawlitzki M, Opel N, Hahn T, Dannlowski U, Pap T, Luessi F, Schreiber JA, Wünsch B, Kuhlmann T, Seebohm G, Tackenberg B, Seja P, Döring F, Wischmeyer E, Chasan AI, Roth J, Klotz L, Meyer Zu Hörste G, Wiendl H, Marschall T, Floess S, Huehn J, Budde T, Bopp T, Bittner S, Meuth SG. K2P18.1 translates T cell receptor signals into thymic regulatory T cell development. Cell Res 2021. [PMID: 34702947 DOI: 10.1038/s41422-021-00580-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Akhbariyoon H, Azizpour Y, Esfahani MF, Firoozabad MSM, Rad MR, Esfahani KS, Khoshavi N, Karimi N, Shirinisaz A, Abedi F, Rad MR, Sharifi P. Immune checkpoint inhibition for the treatment of cancers: An update and critical review of ongoing clinical trials. Clin Immunol 2021;232:108873. [PMID: 34688855 DOI: 10.1016/j.clim.2021.108873] [Reference Citation Analysis]
14 Market M, Tennakoon G, Auer RC. Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery. Int J Mol Sci 2021;22:11378. [PMID: 34768810 DOI: 10.3390/ijms222111378] [Reference Citation Analysis]
15 Korbecki J, Simińska D, Gąssowska-Dobrowolska M, Listos J, Gutowska I, Chlubek D, Baranowska-Bosiacka I. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms. Int J Mol Sci 2021;22:10701. [PMID: 34639040 DOI: 10.3390/ijms221910701] [Reference Citation Analysis]
16 Lilburn DM, Groves AM. The role of PET in imaging of the tumour microenvironment and response to immunotherapy. Clinical Radiology 2021;76:784.e1-784.e15. [DOI: 10.1016/j.crad.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Böckle D, Rasche L, Martin Kortüm K, Lutz MB, Einsele H, Brandl A, Beilhack A. Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression. Leukemia 2021. [PMID: 34584204 DOI: 10.1038/s41375-021-01422-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Shen X, Huang S, Xiao H, Zeng S, Liu J, Ran Z, Xiong B. Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis. Eur J Hosp Pharm 2021:ejhpharm-2021-002803. [PMID: 34497128 DOI: 10.1136/ejhpharm-2021-002803] [Reference Citation Analysis]
19 Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif 2021;54:e13115. [PMID: 34464477 DOI: 10.1111/cpr.13115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
20 Bayless S, Travers JB, Sahu RP, Rohan CA. Inhibition of photodynamic therapy induced-immunosuppression with aminolevulinic acid leads to enhanced outcomes of tumors and pre-cancerous lesions. Oncol Lett 2021;22:664. [PMID: 34386086 DOI: 10.3892/ol.2021.12925] [Reference Citation Analysis]
21 Soongsathitanon J, Jamjuntra P, Sumransub N, Yangngam S, De la Fuente M, Landskron G, Thuwajit P, Hermoso MA, Thuwajit C. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer. J Immunol Res 2021;2021:8840066. [PMID: 34337083 DOI: 10.1155/2021/8840066] [Reference Citation Analysis]
22 Wang H, Che Y, Yang Y, Suo J, Wang X. Inhibition of Orthotopic Genital Cancer Induced by Subcutaneous Administration of Human Papillomavirus Peptide Vaccine with CpG Oligodeoxynucleotides as an Adjuvant in Mice. Cancer Manag Res 2021;13:5559-72. [PMID: 34285577 DOI: 10.2147/CMAR.S309226] [Reference Citation Analysis]
23 Ren P, Wang J, Li L, Lin X, Wu G, Chen J, Zeng Z, Zhang H. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis. Bioengineered 2021;12:3188-200. [PMID: 34238116 DOI: 10.1080/21655979.2021.1943986] [Reference Citation Analysis]
24 Ahmad RS, Eubank TD, Lukomski S, Boone BA. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. Biomolecules 2021;11:901. [PMID: 34204306 DOI: 10.3390/biom11060901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Zhang Y, Wang X, Zhang R, Wang X, Fu H, Yang W. MDSCs interactions with other immune cells and their role in maternal-fetal tolerance. Int Rev Immunol 2021;:1-18. [PMID: 34128752 DOI: 10.1080/08830185.2021.1938566] [Reference Citation Analysis]
26 Ashrafizadeh M, Mohammadinejad R, Samarghandian S, Yaribeygi H, Johnston TP, Sahebkar A. Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms. Anticancer Agents Med Chem 2020;20:918-31. [PMID: 32108003 DOI: 10.2174/1871520620666200228110704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Han L, Sun Y, Lu C, Ma C, Shi J, Sun D. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer. Front Genet 2021;12:666833. [PMID: 34127929 DOI: 10.3389/fgene.2021.666833] [Reference Citation Analysis]
28 Kwiatkowska I, Hermanowicz JM, Przybyszewska-Podstawka A, Pawlak D. Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis. Cancers (Basel) 2021;13:2667. [PMID: 34071442 DOI: 10.3390/cancers13112667] [Reference Citation Analysis]
29 Holmberg-Thyden S, Grønbæk K, Gang AO, El Fassi D, Hadrup SR. A user's guide to multicolor flow cytometry panels for comprehensive immune profiling. Anal Biochem 2021;627:114210. [PMID: 34033799 DOI: 10.1016/j.ab.2021.114210] [Reference Citation Analysis]
30 Liu MF, Jin C, Wu T, Chen EH, Lu M, Qin HL. Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patients. Immunol Res 2021;69:275-84. [PMID: 33959834 DOI: 10.1007/s12026-021-09200-9] [Reference Citation Analysis]
31 Yagi H, Nakaguro M, Ito M, Okumura Y, Takahashi S, Aoshima Y, Enomoto Y, Meguro S, Kawasaki H, Kosugi I, Shimoyama Y, Ogawa H, Tateyama H, Iwashita T. Difference in the distribution of tumor-infiltrating CD8+ T cells and FOXP3+ T cells between micronodular thymoma with lymphoid stroma and micronodular thymic carcinoma with lymphoid stroma. Pathol Int 2021;71:453-62. [PMID: 33819365 DOI: 10.1111/pin.13099] [Reference Citation Analysis]
32 Paston SJ, Brentville VA, Symonds P, Durrant LG. Cancer Vaccines, Adjuvants, and Delivery Systems. Front Immunol 2021;12:627932. [PMID: 33859638 DOI: 10.3389/fimmu.2021.627932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Wendel P, Reindl LM, Bexte T, Künnemeyer L, Särchen V, Albinger N, Mackensen A, Rettinger E, Bopp T, Ullrich E. Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy. Cancers (Basel) 2021;13:1481. [PMID: 33807011 DOI: 10.3390/cancers13061481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Zhang C, Dang D, Liu C, Wang Y, Cong X. Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma. J Cancer 2021;12:2440-9. [PMID: 33758620 DOI: 10.7150/jca.53697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kamath V. Cancer vaccines: An unkept promise? Drug Discov Today 2021;26:1347-52. [PMID: 33601016 DOI: 10.1016/j.drudis.2021.02.006] [Reference Citation Analysis]
36 Yu C, Zhou L, Zhang Q. Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance. Int Immunopharmacol 2021;94:107473. [PMID: 33611062 DOI: 10.1016/j.intimp.2021.107473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vogl M, Rosenmayr A, Bohanes T, Scheed A, Brndiar M, Stubenberger E, Ghanim B. Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation. Cancers (Basel) 2021;13:658. [PMID: 33562138 DOI: 10.3390/cancers13040658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Wu J, Abraham SN. The Roles of T cells in Bladder Pathologies. Trends Immunol 2021;42:248-60. [PMID: 33536141 DOI: 10.1016/j.it.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Liu Q, Duo Y, Fu J, Qiu M, Sun Z, Adah D, Kang J, Xie Z, Fan T, Bao S, Zhang H, Liu L, Cao Y. Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy. Nano Today 2021;36:101023. [DOI: 10.1016/j.nantod.2020.101023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
40 Weber M, Homm A, Müller S, Frey S, Amann K, Ries J, Geppert C, Preidl R, Möst T, Kämmerer PW, Kesting M, Wehrhan F. Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo. Int J Mol Sci 2021;22:1323. [PMID: 33525753 DOI: 10.3390/ijms22031323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Hu-Lieskovan S, Malouf GG, Jacobs I, Chou J, Liu L, Johnson ML. Addressing resistance to immune checkpoint inhibitor therapy: an urgent unmet need. Future Oncol 2021;17:1401-39. [PMID: 33475012 DOI: 10.2217/fon-2020-0967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Haist M, Stege H, Grabbe S, Bros M. The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment. Cancers (Basel) 2021;13:E210. [PMID: 33430105 DOI: 10.3390/cancers13020210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Tang D, Huang W, Yang Z, Wu X, Sang X, Wang K, Cao G, Hao M. Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I-II colonic carcinoma. J Biochem Mol Toxicol 2021;35:e22703. [PMID: 33410236 DOI: 10.1002/jbt.22703] [Reference Citation Analysis]
44 Ye LL, Peng WB, Niu YR, Xiang X, Wei XS, Wang ZH, Wang X, Zhang SY, Chen X, Zhou Q. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Ann Transl Med 2020;8:1647. [PMID: 33490159 DOI: 10.21037/atm-20-7181] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
45 Luo J, Liu P, Wang L, Huang Y, Wang Y, Geng W, Chen D, Bai Y, Yang Z. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis. BMC Cancer 2020;20:1071. [PMID: 33167940 DOI: 10.1186/s12885-020-07532-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Domvri K, Petanidis S, Zarogoulidis P, Anestakis D, Tsavlis D, Bai C, Huang H, Freitag L, Hohenforst-Schmidt W, Porpodis K, Katopodi T. Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis. Clin Immunol 2021;222:108620. [PMID: 33176208 DOI: 10.1016/j.clim.2020.108620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Dong Q, Li G, Fozza C, Wang S, Yang S, Sang Y, Liu X, Chen C. Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia. Biomed Res Int 2020;2020:7023168. [PMID: 33083479 DOI: 10.1155/2020/7023168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Peng F, Qin Y, Mu S, Li J, Ai L, Hu Y. Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol 2020;146:3123-35. [PMID: 32995955 DOI: 10.1007/s00432-020-03398-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Du B, Du Q, Bai Y, Yu L, Wang Y, Huang J, Zheng M, Shen G, Zhou J, Yao H. Chemotherapy based on "Domino-effect" combined with immunotherapy amplifying the efficacy of an anti-metastatic treatment. J Mater Chem B 2020. [PMID: 32945310 DOI: 10.1039/d0tb01061h] [Reference Citation Analysis]
50 Bockamp E, Rosigkeit S, Siegl D, Schuppan D. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology. Cells 2020;9:E2102. [PMID: 32942725 DOI: 10.3390/cells9092102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Hager S, Fittler FJ, Wagner E, Bros M. Nucleic Acid-Based Approaches for Tumor Therapy. Cells 2020;9:E2061. [PMID: 32917034 DOI: 10.3390/cells9092061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
52 Liu XJ, Guan QL. Mechanisms of resistance to immune checkpoint inhibitors. Shijie Huaren Xiaohua Zazhi 2020; 28(17): 857-864 [DOI: 10.11569/wcjd.v28.i17.857] [Reference Citation Analysis]
53 Marone G, Schroeder JT, Mattei F, Loffredo S, Gambardella AR, Poto R, de Paulis A, Schiavoni G, Varricchi G. Is There a Role for Basophils in Cancer? Front Immunol 2020;11:2103. [PMID: 33013885 DOI: 10.3389/fimmu.2020.02103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
54 Zou Y, Ruan S, Jin L, Chen Z, Han H, Zhang Y, Jian Z, Lin Y, Shi N, Jin H. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma. Med Sci Monit 2020;26:e925289. [PMID: 32863381 DOI: 10.12659/MSM.925289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
55 Jakubowska K, Koda M, Kisielewski W, Kańczuga-Koda L, Grudzińska M, Famulski W. Pre- and postoperative neutrophil and lymphocyte count and neutrophil-to-lymphocyte ratio in patients with colorectal cancer. Mol Clin Oncol 2020;13:56. [PMID: 32905328 DOI: 10.3892/mco.2020.2126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
56 Abbasi A, Pakravan N, Hassan ZM. Hyaluronic acid optimises therapeutic effects of hydrogen peroxide-induced oxidative stress on breast cancer. J Cell Physiol 2021;236:1494-514. [PMID: 32740942 DOI: 10.1002/jcp.29957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
57 Kim HM, Koo JS. Clinicopathologic Characteristics of Breast Cancer According to the Infiltrating Immune Cell Subtypes. Int J Mol Sci 2020;21:E4438. [PMID: 32580398 DOI: 10.3390/ijms21124438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
58 Solary E, Laplane L. The role of host environment in cancer evolution. Evol Appl 2020;13:1756-70. [DOI: 10.1111/eva.13039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
59 Hou A, Hou K, Huang Q, Lei Y, Chen W. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors. Front Immunol 2020;11:783. [PMID: 32508809 DOI: 10.3389/fimmu.2020.00783] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Chen GG, Woo PYM, Ng SCP, Wong GKC, Chan DTM, van Hasselt CA, Tong MCF, Poon WS. Impact of metformin on immunological markers: Implication in its anti-tumor mechanism. Pharmacol Ther 2020;213:107585. [PMID: 32473961 DOI: 10.1016/j.pharmthera.2020.107585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Hou A, Hou K, Huang Q, Lei Y, Chen W. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors. Front Immunol 2020;11:783. [PMID: 32508809 DOI: 10.3389/fimmu.2020.00783] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
62 Mendoza-Reinoso V, McCauley LK, Fournier PGJ. Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers (Basel) 2020;12:E1014. [PMID: 32326073 DOI: 10.3390/cancers12041014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
63 Bujak JK, Szopa IM, Pingwara R, Kruczyk O, Krzemińska N, Mucha J, Majchrzak-Kuligowska K. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors. Int J Mol Sci 2020;21:E2292. [PMID: 32225066 DOI: 10.3390/ijms21072292] [Reference Citation Analysis]
64 Cao M, Wang Y, Wang D, Duan Y, Hong W, Zhang N, Shah W, Wang Y, Chen H. Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients. Am J Clin Pathol 2020;153:502-12. [PMID: 31819948 DOI: 10.1093/ajcp/aqz186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
65 Hu J, Wu X, Huang P, Teng F, Wang Y, Xue F. The Proportion and Prognostic Significance of T-Regulatory Cells in Patients with Gynecological Cancers: A Systematic Review and Meta-Analysis. J Cancer 2020;11:3340-8. [PMID: 32231740 DOI: 10.7150/jca.42472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
66 Efremov SM, Kozireva VS, Moroz GB, Abubakirov MN, Shkoda OS, Shilova AN, Yarmoshuk SV, Zheravin AA, Landoni G, Lomivorotov VV. The immunosuppressive effects of volatile versus intravenous anesthesia combined with epidural analgesia on kidney cancer: a pilot randomized controlled trial. Korean J Anesthesiol 2020;73:525-33. [PMID: 32098012 DOI: 10.4097/kja.19461] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Wen Q, Han T, Wang Z, Jiang S. Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape. Oncol Lett. 2020;19:2595-2601. [PMID: 32218809 DOI: 10.3892/ol.2020.11369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
68 Malyshev IY, Kuznetsova LV, Mardente S. Cancer immunotherapy through the prism of adaptation: Will Achilles catch the tortoise? Med Hypotheses 2020;137:109545. [PMID: 31952020 DOI: 10.1016/j.mehy.2019.109545] [Reference Citation Analysis]
69 Magnotti EL, Chan LL, Zhu Q, Marasco WA. A high-throughput chemotaxis detection method for CCR4+ T cell migration inhibition using image cytometry. J Immunol Methods 2020;479:112747. [PMID: 31958449 DOI: 10.1016/j.jim.2020.112747] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Kim JH, Hwang J, Jung JH, Lee HJ, Lee DY, Kim SH. Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression. Mol Cancer 2019;18:180. [PMID: 31815635 DOI: 10.1186/s12943-019-1110-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
71 Sun B, Liu M, Cui M, Li T. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells. Immunol Lett 2020;217:7-14. [PMID: 31669380 DOI: 10.1016/j.imlet.2019.10.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
72 Bianco A, Perrotta F, Barra G, Malapelle U, Rocco D, De Palma R. Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer. Int J Mol Sci 2019;20:E4931. [PMID: 31590386 DOI: 10.3390/ijms20194931] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
73 Alissafi T, Hatzioannou A, Legaki AI, Varveri A, Verginis P. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells. J Autoimmun 2019;104:102310. [PMID: 31421963 DOI: 10.1016/j.jaut.2019.102310] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
74 Saleh R, Elkord E. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression. Semin Cancer Biol 2020;65:13-27. [PMID: 31362073 DOI: 10.1016/j.semcancer.2019.07.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 17.3] [Reference Citation Analysis]
75 Wang D, Wang M, Wang A, Li J, Li X, Jian H, Bai S, Yin J. Preparation of collagen/chitosan microspheres for 3D macrophage proliferation in vitro. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2019;572:266-73. [DOI: 10.1016/j.colsurfa.2019.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Liu P, Xiao Q, Zhou B, Dai Z, Kang Y. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma. World Neurosurg 2019;129:e240-54. [PMID: 31128313 DOI: 10.1016/j.wneu.2019.05.121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
77 Fares CM, Van Allen EM, Drake CG, Allison JP, Hu-Lieskovan S. Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients? Am Soc Clin Oncol Educ Book 2019;39:147-64. [PMID: 31099674 DOI: 10.1200/EDBK_240837] [Cited by in Crossref: 187] [Cited by in F6Publishing: 129] [Article Influence: 62.3] [Reference Citation Analysis]
78 Luo L, Lv M, Zhuang X, Zhang Q, Qiao T. Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo. Onco Targets Ther 2019;12:3805-15. [PMID: 31190880 DOI: 10.2147/OTT.S197516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
79 Saleh R, Elkord E. Treg-mediated acquired resistance to immune checkpoint inhibitors. Cancer Lett 2019;457:168-79. [PMID: 31078738 DOI: 10.1016/j.canlet.2019.05.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 19.0] [Reference Citation Analysis]
80 Mohr A, Atif M, Balderas R, Gorochov G, Miyara M. The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases. Clin Exp Immunol 2019;197:24-35. [PMID: 30830965 DOI: 10.1111/cei.13288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
81 Xiang L, Gilkes DM. The Contribution of the Immune System in Bone Metastasis Pathogenesis. Int J Mol Sci 2019;20:E999. [PMID: 30823602 DOI: 10.3390/ijms20040999] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
82 Han Y, Jo H, Cho JH, Dhanasekaran DN, Song YS. Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer. Int J Mol Sci 2019;20:E925. [PMID: 30791624 DOI: 10.3390/ijms20040925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
83 Yang Y, Che Y, Zhao Y, Wang X. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo. Int Immunopharmacol 2019;69:279-88. [PMID: 30743204 DOI: 10.1016/j.intimp.2019.01.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
84 Market M, Baxter KE, Angka L, Kennedy MA, Auer RC. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction. Cancers (Basel) 2018;11:E2. [PMID: 30577463 DOI: 10.3390/cancers11010002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
85 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
86 Conway JR, Kofman E, Mo SS, Elmarakeby H, Van Allen E. Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Med 2018;10:93. [PMID: 30497521 DOI: 10.1186/s13073-018-0605-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 70] [Article Influence: 15.0] [Reference Citation Analysis]